1 Supply Summary 1.1 Next Generation Cancer Treatment Introduction 1.2 World Next Generation Cancer Treatment Market Size & Forecast (2017 & 2021 & 2028) 1.3 World Next Generation Cancer Treatment Total Market by Region 1.3.1 World Next Generation Cancer Treatment Market Size by Region (2017-2028) 1.3.2 United States Next Generation Cancer Treatment Market Size (2017-2028) 1.3.3 China Next Generation Cancer Treatment Market Size (2017-2028) 1.3.4 Europe Next Generation Cancer Treatment Market Size (2017-2028) 1.3.5 Japan Next Generation Cancer Treatment Market Size (2017-2028) 1.3.6 South Korea Next Generation Cancer Treatment Market Size (2017-2028) 1.3.7 ASEAN Next Generation Cancer Treatment Market Size (2017-2028) 1.3.8 India Next Generation Cancer Treatment Market Size (2017-2028) 1.4 Market Drivers, Restraints and Trends 1.4.1 Next Generation Cancer Treatment Market Drivers 1.4.2 Factors Affecting Demand 1.4.3 Next Generation Cancer Treatment Major Market Trends 1.5 Influence of COVID-19 and Russia-Ukraine War 1.5.1 Influence of COVID-19 1.5.2 Influence of Russia-Ukraine War 2 World Next Generation Cancer Treatment Companies Competitive Analysis 2.1 World Next Generation Cancer Treatment Revenue by Player (2017-2022) 2.2 Industry Rank and Concentration Rate (CR) 2.2.1 Global Next Generation Cancer Treatment Industry Rank of Major Players 2.2.2 Global Concentration Ratios (CR4) for Next Generation Cancer Treatment in 2021 2.2.3 Global Concentration Ratios (CR8) for Next Generation Cancer Treatment in 2021 2.3 Next Generation Cancer Treatment Company Evaluation Quadrant 2.4 Next Generation Cancer Treatment Market: Overall Company Footprint Analysis 2.4.1 Next Generation Cancer Treatment Market: Region Footprint 2.4.2 Next Generation Cancer Treatment Market: Company Product Type Footprint 2.4.3 Next Generation Cancer Treatment Market: Company Product Application Footprint 2.5 Competitive Environment 2.5.1 Historical Structure of the Industry 2.5.2 Barriers of Market Entry 2.5.3 Factors of Competition 2.6 Mergers, Acquisitions Activity 3 United States VS China VS Rest of the World 3.1 United States VS China: Next Generation Cancer Treatment Market Comparison 3.1.1 United States VS China: Next Generation Cancer Treatment Market Size Comparison (2017 & 2021 & 2028) 3.1.2 United States VS China: Next Generation Cancer Treatment Market Size Market Share Comparison (2017 & 2021 & 2028) 3.2 United States Next Generation Cancer Treatment Major Players and Market Share, 2017-2022 3.2.1 Major Players of Next Generation Cancer Treatment in United States, Headquarters (States, Country) 3.2.2 United States Next Generation Cancer Treatment Revenue by Domestic Player, (2017-2022) 3.3 China Next Generation Cancer Treatment Major Players and Market Share, 2017-2022 3.3.1 Major Players of Next Generation Cancer Treatment in China, Headquarters (Province, Country) 3.3.2 China Next Generation Cancer Treatment Revenue by Domestic Player, (2017-2022) 3.4 Rest of World Next Generation Cancer Treatment Major Players and Market Share, 2017-2022 3.4.1 Major Players of Next Generation Cancer Treatment in Rest of World, Headquarters (State, Country) 3.4.2 Rest of World Next Generation Cancer Treatment Revenue by Domestic Player, (2017-2022) 4 Market Analysis by Type 4.1 World Next Generation Cancer Treatment Market Size Overview by Type: 2017 VS 2021 VS 2028 4.2 Segment Introduction by Type 4.2.1 CAR-T Therapy 4.2.2 Targeted Cancer Therapy 4.2.3 Others 4.3 Market Segment by Type 4.3.1 World Next Generation Cancer Treatment Market Size by Type (2017-2022) 4.3.2 World Next Generation Cancer Treatment Market Size by Type (2023-2028) 4.3.3 World Next Generation Cancer Treatment Market Size Market Share by Type (2017-2028) 5 Market Analysis by Application 5.1 World Next Generation Cancer Treatment Market Size Overview by Application: 2017 VS 2021 VS 2028 5.2 Segment Introduction by Application 5.2.1 Lung Cancer 5.2.2 Colorectal Cancer 5.2.3 Stomach Cancer 5.2.4 Breast Cancer 5.2.5 Breast Cancer 5.2.6 Others 5.3 Market Segment by Application 5.3.1 World Next Generation Cancer Treatment Market Size by Application (2017-2022) 5.3.2 World Next Generation Cancer Treatment Market Size by Application (2023-2028) 5.3.3 World Next Generation Cancer Treatment Market Size by Application (2017-2028) 6 Company Profiles 6.1 OncoGenex Pharmaceuticals, Inc. 6.1.1 OncoGenex Pharmaceuticals, Inc. Details 6.1.2 OncoGenex Pharmaceuticals, Inc. Major Business 6.1.3 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Product and Services 6.1.4 OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.1.5 OncoGenex Pharmaceuticals, Inc. Recent Developments/Updates 6.1.6 OncoGenex Pharmaceuticals, Inc. Competitive Strengths & Weaknesses 6.2 Cytokinetics Inc. 6.2.1 Cytokinetics Inc. Details 6.2.2 Cytokinetics Inc. Major Business 6.2.3 Cytokinetics Inc. Next Generation Cancer Treatment Product and Services 6.2.4 Cytokinetics Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.2.5 Cytokinetics Inc. Recent Developments/Updates 6.2.6 Cytokinetics Inc. Competitive Strengths & Weaknesses 6.3 Hospira Inc. 6.3.1 Hospira Inc. Details 6.3.2 Hospira Inc. Major Business 6.3.3 Hospira Inc. Next Generation Cancer Treatment Product and Services 6.3.4 Hospira Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.3.5 Hospira Inc. Recent Developments/Updates 6.3.6 Hospira Inc. Competitive Strengths & Weaknesses 6.4 GlaxoSmithKline plc 6.4.1 GlaxoSmithKline plc Details 6.4.2 GlaxoSmithKline plc Major Business 6.4.3 GlaxoSmithKline plc Next Generation Cancer Treatment Product and Services 6.4.4 GlaxoSmithKline plc Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.4.5 GlaxoSmithKline plc Recent Developments/Updates 6.4.6 GlaxoSmithKline plc Competitive Strengths & Weaknesses 6.5 Boehringer Ingelheim GmbH 6.5.1 Boehringer Ingelheim GmbH Details 6.5.2 Boehringer Ingelheim GmbH Major Business 6.5.3 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Product and Services 6.5.4 Boehringer Ingelheim GmbH Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.5.5 Boehringer Ingelheim GmbH Recent Developments/Updates 6.5.6 Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses 6.6 Bayer HealthCare AG 6.6.1 Bayer HealthCare AG Details 6.6.2 Bayer HealthCare AG Major Business 6.6.3 Bayer HealthCare AG Next Generation Cancer Treatment Product and Services 6.6.4 Bayer HealthCare AG Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.6.5 Bayer HealthCare AG Recent Developments/Updates 6.6.6 Bayer HealthCare AG Competitive Strengths & Weaknesses 6.7 Abbott Laboratories 6.7.1 Abbott Laboratories Details 6.7.2 Abbott Laboratories Major Business 6.7.3 Abbott Laboratories Next Generation Cancer Treatment Product and Services 6.7.4 Abbott Laboratories Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.7.5 Abbott Laboratories Recent Developments/Updates 6.7.6 Abbott Laboratories Competitive Strengths & Weaknesses 6.8 Walking Fish Therapeutics 6.8.1 Walking Fish Therapeutics Details 6.8.2 Walking Fish Therapeutics Major Business 6.8.3 Walking Fish Therapeutics Next Generation Cancer Treatment Product and Services 6.8.4 Walking Fish Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.8.5 Walking Fish Therapeutics Recent Developments/Updates 6.8.6 Walking Fish Therapeutics Competitive Strengths & Weaknesses 6.9 Kojin Therapeutics 6.9.1 Kojin Therapeutics Details 6.9.2 Kojin Therapeutics Major Business 6.9.3 Kojin Therapeutics Next Generation Cancer Treatment Product and Services 6.9.4 Kojin Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.9.5 Kojin Therapeutics Recent Developments/Updates 6.9.6 Kojin Therapeutics Competitive Strengths & Weaknesses 6.10 Scorpion Therapeutics 6.10.1 Scorpion Therapeutics Details 6.10.2 Scorpion Therapeutics Major Business 6.10.3 Scorpion Therapeutics Next Generation Cancer Treatment Product and Services 6.10.4 Scorpion Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) 6.10.5 Scorpion Therapeutics Recent Developments/Updates 6.10.6 Scorpion Therapeutics Competitive Strengths & Weaknesses 7 Raw Material and Industry Chain 7.1 Raw Material of Next Generation Cancer Treatment and Key Manufacturers 7.2 Next Generation Cancer Treatment Manufacturing Costs 7.3 Next Generation Cancer Treatment Production Process 7.4 Next Generation Cancer Treatment Industrial Chain 8 Distribution Channel Analysis 8.1 Distribution Channel Breakdown for Next Generation Cancer Treatment Shipments (%): 2017-2028 8.1.1 Direct Channel 8.1.2 Indirect Channel 8.2 Next Generation Cancer Treatment Typical Distributors 8.3 Next Generation Cancer Treatment Typical Customers 9 Research Findings and Conclusion 10 Appendix 10.1 Methodology 10.2 Research Process and Data Source 10.3 Disclaimer

List of Tables Table 1. World Next Generation Cancer Treatment Market Size by Region (2017, 2022 and 2028) & (USD Million) Table 2. World Next Generation Cancer Treatment Market Size by Region (2017-2022) & (USD Million) Table 3. World Next Generation Cancer Treatment Market Size by Region (2023-2028) & (USD Million) Table 4. World Next Generation Cancer Treatment Market Size Market Share by Region (2017-2022) Table 5. World Next Generation Cancer Treatment Market Size Market Share by Region (2023-2028) Table 6. Major Market Trends Table 7. World Next Generation Cancer Treatment Revenue by Player (2017-2022) & (USD Million) Table 8. Revenue Market Share of Key Next Generation Cancer Treatment Players in 2021 Table 9. World Next Generation Cancer Treatment Industry Rank of Major Player, Based on Revenue in 2021 Table 10. Global Next Generation Cancer Treatment Company Evaluation Quadrant Table 11. Head Office of Key Next Generation Cancer Treatment Player Table 12. Next Generation Cancer Treatment Market: Company Product Type Footprint Table 13. Next Generation Cancer Treatment Market: Company Product Application Footprint Table 14. Next Generation Cancer Treatment Mergers & Acquisitions Activity Table 15. United States VS China Next Generation Cancer Treatment Market Size Comparison, (2017 & 2021 & 2028) & (USD Million) Table 16. Major Player of Next Generation Cancer Treatment in United States, Headquarters (States, Country) Table 17. United States Next Generation Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million) Table 18. United States Next Generation Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022) Table 19. Major Player of Next Generation Cancer Treatment in China, Company Headquarters (Province, Country) Table 20. China Next Generation Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million) Table 21. China Next Generation Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022) Table 22. Major Player of Next Generation Cancer Treatment in Rest of World, Company Headquarters (State, Country) Table 23. Rest of World Next Generation Cancer Treatment Revenue by Domestic Player, (2017-2022) & (USD Million) Table 24. Rest of World Next Generation Cancer Treatment Revenue Market Share by Domestic Player, (2017-2022) Table 25. World Next Generation Cancer Treatment Revenue by Type, (USD Million), 2017 & 2021 & 2028 Table 26. World Next Generation Cancer Treatment Revenue by Type (2017-2022) & (USD Million) Table 27. World Next Generation Cancer Treatment Revenue by Type (2023-2028) & (USD Million) Table 28. World Next Generation Cancer Treatment Revenue by Application, (USD Million), 2017 & 2021 & 2028 Table 29. World Next Generation Cancer Treatment Revenue by Application (2017-2022) & (USD Million) Table 30. World Next Generation Cancer Treatment Revenue by Application (2023-2028) & (USD Million) Table 31. OncoGenex Pharmaceuticals, Inc. Basic Information, Area Served and Competitors Table 32. OncoGenex Pharmaceuticals, Inc. Major Business Table 33. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Product and Services Table 34. OncoGenex Pharmaceuticals, Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 35. OncoGenex Pharmaceuticals, Inc. Recent Developments/Updates Table 36. OncoGenex Pharmaceuticals, Inc. Competitive Strengths & Weaknesses Table 37. Cytokinetics Inc. Basic Information, Area Served and Competitors Table 38. Cytokinetics Inc. Major Business Table 39. Cytokinetics Inc. Next Generation Cancer Treatment Product and Services Table 40. Cytokinetics Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 41. Cytokinetics Inc. Recent Developments/Updates Table 42. Cytokinetics Inc. Competitive Strengths & Weaknesses Table 43. Hospira Inc. Basic Information, Area Served and Competitors Table 44. Hospira Inc. Major Business Table 45. Hospira Inc. Next Generation Cancer Treatment Product and Services Table 46. Hospira Inc. Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 47. Hospira Inc. Recent Developments/Updates Table 48. Hospira Inc. Competitive Strengths & Weaknesses Table 49. GlaxoSmithKline plc Basic Information, Area Served and Competitors Table 50. GlaxoSmithKline plc Major Business Table 51. GlaxoSmithKline plc Next Generation Cancer Treatment Product and Services Table 52. GlaxoSmithKline plc Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 53. GlaxoSmithKline plc Recent Developments/Updates Table 54. GlaxoSmithKline plc Competitive Strengths & Weaknesses Table 55. Boehringer Ingelheim GmbH Basic Information, Area Served and Competitors Table 56. Boehringer Ingelheim GmbH Major Business Table 57. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Product and Services Table 58. Boehringer Ingelheim GmbH Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 59. Boehringer Ingelheim GmbH Recent Developments/Updates Table 60. Boehringer Ingelheim GmbH Competitive Strengths & Weaknesses Table 61. Bayer HealthCare AG Basic Information, Area Served and Competitors Table 62. Bayer HealthCare AG Major Business Table 63. Bayer HealthCare AG Next Generation Cancer Treatment Product and Services Table 64. Bayer HealthCare AG Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 65. Bayer HealthCare AG Recent Developments/Updates Table 66. Bayer HealthCare AG Competitive Strengths & Weaknesses Table 67. Abbott Laboratories Basic Information, Area Served and Competitors Table 68. Abbott Laboratories Major Business Table 69. Abbott Laboratories Next Generation Cancer Treatment Product and Services Table 70. Abbott Laboratories Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 71. Abbott Laboratories Recent Developments/Updates Table 72. Abbott Laboratories Competitive Strengths & Weaknesses Table 73. Walking Fish Therapeutics Basic Information, Area Served and Competitors Table 74. Walking Fish Therapeutics Major Business Table 75. Walking Fish Therapeutics Next Generation Cancer Treatment Product and Services Table 76. Walking Fish Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 77. Walking Fish Therapeutics Recent Developments/Updates Table 78. Walking Fish Therapeutics Competitive Strengths & Weaknesses Table 79. Kojin Therapeutics Basic Information, Area Served and Competitors Table 80. Kojin Therapeutics Major Business Table 81. Kojin Therapeutics Next Generation Cancer Treatment Product and Services Table 82. Kojin Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 83. Kojin Therapeutics Recent Developments/Updates Table 84. Scorpion Therapeutics Basic Information, Area Served and Competitors Table 85. Scorpion Therapeutics Major Business Table 86. Scorpion Therapeutics Next Generation Cancer Treatment Product and Services Table 87. Scorpion Therapeutics Next Generation Cancer Treatment Revenue, Gross Margin and Market Share (2017-2022) & (USD Million) Table 88. Next Generation Cancer Treatment Raw Material Table 89. Key Manufacturers of Next Generation Cancer Treatment Raw Materials Table 90. Next Generation Cancer Treatment Typical Distributors Table 91. Next Generation Cancer Treatment Typical Customers List of Figure Figure 1. Next Generation Cancer Treatment Picture Figure 2. World Next Generation Cancer Treatment Total Market Size: 2017 & 2021 & 2028, (USD Million) Figure 3. World Next Generation Cancer Treatment Total Market Size (2017-2028) & (USD Million) Figure 4. World Next Generation Cancer Treatment Market Size Market Share by Region (2017-2028) Figure 5. United States Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 6. China Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 7. Europe Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 8. Japan Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 9. South Korea Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 10. ASEAN Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 11. India Next Generation Cancer Treatment Market Size (2017-2028) & (USD Million) Figure 12. Next Generation Cancer Treatment Market Drivers Figure 13. Factors Affecting Demand Figure 14. Producer Shipments of Next Generation Cancer Treatment by Player Revenue ($MM) and Market Share (%): 2021 Figure 15. Global Four-firm Concentration Ratios (CR4) for Next Generation Cancer Treatment Markets in 2021 Figure 16. Global Four-firm Concentration Ratios (CR8) for Next Generation Cancer Treatment Markets in 2021 Figure 17. United States VS China: Next Generation Cancer Treatment Market Size Market Share Comparison (2017 & 2021 & 2028) Figure 18. World Next Generation Cancer Treatment Market Size by Type, (USD Million), 2017 & 2021 & 2028 Figure 19. World Next Generation Cancer Treatment Market Size Market Share by Type in 2021 Figure 20. CAR-T Therapy Figure 21. Targeted Cancer Therapy Figure 22. Others Figure 23. World Next Generation Cancer Treatment Market Size Market Share by Type (2017-2028) Figure 24. World Next Generation Cancer Treatment Market Size by Application, (USD Million), 2017 & 2021 & 2028 Figure 25. World Next Generation Cancer Treatment Market Size Market Share by Application in 2021 Figure 26. Lung Cancer Figure 27. Colorectal Cancer Figure 28. Stomach Cancer Figure 29. Breast Cancer Figure 30. Liver Cancer Figure 31. Others Figure 32. World Next Generation Cancer Treatment Market Size Market Share by Application (2017-2028) Figure 33. Manufacturing Cost Structure Analysis of Next Generation Cancer Treatment in 2021 Figure 34. Manufacturing Process Analysis of Next Generation Cancer Treatment Figure 35. Next Generation Cancer Treatment Industrial Chain Figure 36. Distribution Channel Breakdown for Next Generation Cancer Treatment Shipments (%): 2017-2028 Figure 37. Direct Channel Pros & Cons Figure 38. Indirect Channel Pros & Cons Figure 39. Methodology Figure 40. Research Process and Data Source

OncoGenex Pharmaceuticals, Inc. Cytokinetics Inc. Hospira Inc. GlaxoSmithKline plc Boehringer Ingelheim GmbH Bayer HealthCare AG Abbott Laboratories Walking Fish Therapeutics Kojin Therapeutics Scorpion Therapeutics